Literature DB >> 2311299

Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis.

F Conceição-Silva1, R C Dórea, C Pirmez, A Schubach, S G Coutinho.   

Abstract

A limiting dilution analysis (LDA) was utilized to estimate the frequency of L. braziliensis braziliensis reactive T cells (Lbb-T cells) in peripheral blood and in the lesions of patients with mild localized cutaneous leishmaniasis (LCL) or with severe mucosal leishmaniasis (MCL). The frequencies of Lbb-T cells in peripheral blood varied from 1:107300 to 1:3587 and were not significantly different in MCL and LCL patients. However, a significant difference was encountered (P less than 0.02) between the T cells frequencies in cutaneous (1:748 to 1:45) and mucosal lesions (1:152 to 1:13). A positive correlation was also observed between these frequencies and the magnitude of delayed-type hypersensitivity (DTH) (P less than 0.01) and the presence of fibrinoid necrosis and granulomatous reaction in the site of the lesions (P less than 0.05). The lack of correlation between the severity of disease (MCL or LCL) and the frequency of Lbb-T cells in peripheral blood gave no indications towards understanding the physiopathology of severe or mild disease. However, the correlation between high T cell frequencies in the site of the lesions, the magnitude of DTH, the fibrinoid necrosis and the severity of the disease (MCL lesions) points to the possibility that the presence of a strong T cell dependent cellular immune response in the site of the lesions may have a deleterious effect. However, a local well modulated T cell immune response might provide healing of the lesions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311299      PMCID: PMC1534771          DOI: 10.1111/j.1365-2249.1990.tb05182.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Immunity in cutaneous leishmaniasis of the guinea-pig.

Authors:  A D Bryceson; R S Bray; R A Wolstencroft; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

2.  In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary culture.

Authors:  H M Gebel; J R Scott; C A Parvin; G E Rodey
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

Review 3.  The in vitro generation and functional analysis of murine T cell populations and clones specific for a protozoan parasite, Leishmania tropica.

Authors:  J A Louis; R H Zubler; S G Coutinho; G Lima; R Behin; J Mauel; H D Engers
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  Cloning of human lymphocytes using limiting dilution.

Authors:  A A Morley; K J Trainor; R S Seshadri
Journal:  Exp Hematol       Date:  1983-05       Impact factor: 3.084

5.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation.

Authors:  D S Ridley; P D Marsden; C C Cuba; A C Barreto
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

7.  T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis.

Authors:  M Castes; M Cabrera; D Trujillo; J Convit
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

Review 8.  The American leishmaniases: some observations on their ecology and epidemiology.

Authors:  R Lainson
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

9.  Characterization of the cellular immune response in American cutaneous leishmaniasis.

Authors:  M Castes; A Agnelli; O Verde; A J Rondón
Journal:  Clin Immunol Immunopathol       Date:  1983-05

10.  Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.

Authors:  J G Howard; C Hale; F Y Liew
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  14 in total

1.  Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.

Authors:  C de Oliveira Mendes-Aguiar; R Vieira-Gonçalves; L H Guimarães; M P de Oliveira-Neto; E M Carvalho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2016-06-06       Impact factor: 4.330

2.  The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.

Authors:  C de O Mendes-Aguiar; A Gomes-Silva; E Nunes; R Pereira-Carvalho; R S Nogueira; M de P Oliveira-Neto; A L Bertho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

3.  Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63).

Authors:  S C Mendonça; D G Russell; S G Coutinho
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

4.  T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.

Authors:  Alda Maria Da-Cruz; Rita Bittar; Marise Mattos; Manuel P Oliveira-Neto; Ricardo Nogueira; Vanessa Pinho-Ribeiro; Rilza Beatriz Azeredo-Coutinho; Sergio G Coutinho
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity.

Authors:  C R Davies; E A Llanos-Cuentas; S D Pyke; C Dye
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

6.  Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment.

Authors:  Luiza C Reis; Maria Edilenza F Brito; Marina A Souza; Angela C R Medeiros; Claudio J Silva; Carlos F Luna; Valéria R A Pereira
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

7.  Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis.

Authors:  A M Da-Cruz; F Conceição-Silva; A L Bertho; S G Coutinho
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Comparative analysis of the nitric oxide production by Leishmania sp.

Authors:  Marcelo Genestra; Wilson Jacinto Silva de Souza; Léa Cysne-Finkelstein; Leonor L Leon
Journal:  Med Microbiol Immunol       Date:  2003-06-21       Impact factor: 3.402

9.  T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasis.

Authors:  A M Cooper; P C Melby; C L Karp; F Neva; D L Sacks
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

10.  Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved.

Authors:  Regina Pereira-Carvalho; Carolina O Mendes-Aguiar; Manoel P Oliveira-Neto; Cláudia J F Covas; Alvaro L Bertho; Alda M Da-Cruz; Adriano Gomes-Silva
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.